Close Menu

Synthetic biology is still a new field — it was only a year ago that the world's first synthetic cell was created at the J. Craig Venter Institute. But while researchers in the field have the innovation needed to create new ideas and look at the creation of cells in a new way, says Technology Review's Katherine Bourzac, the expense and time it takes to get from idea to "engineered organism" is still holding them back.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.